{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":112,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":112,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"29eb746b1fcf","filters":{"venue":"Clinical Colorectal Cancer"}},"results":[{"id":"W2324519287","doi":"10.1016/j.clcc.2016.03.003","title":"Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Medicine; Sigmoidoscopy; Colonoscopy; Colorectal cancer; Internal medicine; Meta-analysis; Cochrane Library; Randomized controlled trial; Fecal occult blood; Incidence (geometry); Relative risk; Perforation; MEDLINE; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.2308279906130682,"gpt":0.4815604429884165,"spread":0.2507324523753482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.002757399,0.001197717,0.02178128,0.0005073992,0.0002652465,0.00008886403,0.0004109587,0.001029877,0.001045662],"category_scores_gemma":[0.002120224,0.0007144569,0.01158014,0.001741173,0.0003769178,0.0001317146,0.0002387876,0.001057069,0.00002604778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005090807,"about_ca_system_score_gemma":0.001010389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001802623,"about_ca_topic_score_gemma":0.0005616517,"domain_scores_codex":[0.9921929,0.0009245545,0.003535809,0.001887538,0.0006570863,0.0008021411],"domain_scores_gemma":[0.9919858,0.003743035,0.002270163,0.0007041905,0.000601151,0.0006956648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0008040426,0.00006985635,0.00002225057,0.6705488,0.2488432,0.00001276722,0.000009382195,3.613472e-7,2.126984e-7,0.00001000175,0.001388914,0.0782902],"study_design_scores_gemma":[0.0006656452,0.001819164,0.00002184135,0.08650742,0.8063597,0.00007512685,0.000004094415,0.00003300579,0.000002380796,0.000008920526,0.103799,0.0007037197],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001382533,0.9846301,0.0005411144,0.0007205571,0.0004805384,0.01160644,0.001608357,0.0002394189,0.0001596224],"genre_scores_gemma":[0.0001051719,0.9701163,0.0003881243,0.001210537,0.0006946237,0.02539073,0.0001261341,0.000175214,0.001793198],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5840414,"threshold_uncertainty_score":0.9998675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967325347","doi":"10.3816/ccc.2002.n.020","title":"Pathologic Prognostic Factors in the Recurrence of Rectal Cancer","year":2002,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Colorectal cancer; Tumor budding; Lymphovascular invasion; Pathological; Mesorectum; Primary tumor; Stage (stratigraphy); Disease; Cancer; Resection margin; Oncology; Radiology; Internal medicine; Surgery; Resection; Metastasis; Lymph node metastasis; Total mesorectal excision","retraction":null,"screen_n_in":null,"score":{"opus":0.2793077972077369,"gpt":0.4909904391691103,"spread":0.2116826419613734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001068881,0.0008900903,0.004654358,0.0002549674,0.00007739793,0.00002881793,0.0007510209,0.001065517,0.001362758],"category_scores_gemma":[0.002261757,0.0004936774,0.001884889,0.001850789,0.0007506709,0.00007763987,0.0002136643,0.002305991,0.00005551824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007708629,"about_ca_system_score_gemma":0.001154372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002938372,"about_ca_topic_score_gemma":0.0003646032,"domain_scores_codex":[0.9934043,0.001287923,0.0024648,0.001252182,0.0008264838,0.0007643705],"domain_scores_gemma":[0.9929876,0.00470913,0.001153339,0.0006521862,0.0002138874,0.0002838853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003246854,0.001129207,0.09700942,0.005863314,0.0003593764,0.0004987317,0.0002212709,6.094843e-7,2.696254e-7,0.000009607774,0.0008097428,0.8937738],"study_design_scores_gemma":[0.002683644,0.005598934,0.1262903,0.04223401,0.005731055,0.0002464112,0.0001012405,0.00002080618,0.000007823883,0.00006616136,0.8157968,0.001222836],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05946051,0.9319186,3.65999e-7,0.0001007848,0.00167161,0.004004528,0.0003990694,0.00006522684,0.002379333],"genre_scores_gemma":[0.04190965,0.9540408,0.00002962577,0.0001293338,0.0005149684,0.003000125,0.00009940037,0.00008488936,0.0001911951],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8925509,"threshold_uncertainty_score":0.9999957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770004975","doi":"10.1016/j.clcc.2017.10.016","title":"A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis","year":2017,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Regorafenib; Medicine; Colorectal cancer; Placebo; Internal medicine; Randomized controlled trial; Hazard ratio; Oncology; Meta-analysis; Randomization; Cochrane Library; Confidence interval; Cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.4372233562728036,"gpt":0.5595940720918068,"spread":0.1223707158190032,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002142418,0.001108043,0.03406132,0.0002194904,0.0003730694,0.00007590852,0.0003698035,0.0004324848,0.0002141709],"category_scores_gemma":[0.001778333,0.0006784055,0.00630722,0.0007411991,0.000829741,0.00008759512,0.0003323863,0.0006799677,0.000002864281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002866726,"about_ca_system_score_gemma":0.0008635721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002787728,"about_ca_topic_score_gemma":0.002337115,"domain_scores_codex":[0.992675,0.0007942048,0.003976292,0.001389892,0.000516335,0.0006482476],"domain_scores_gemma":[0.9902324,0.003696342,0.004309657,0.0007471278,0.0005778273,0.0004366349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0003418218,0.0002442634,0.0006480559,0.6286212,0.3386221,0.00001423618,0.00005425316,0.000001343529,4.165706e-8,0.00002563313,0.002174027,0.02925314],"study_design_scores_gemma":[0.0009526655,0.001854247,0.0002085536,0.06476397,0.8586139,0.00002656024,0.00002092773,0.00006403609,5.624401e-7,0.00002151756,0.0729496,0.000523469],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001015989,0.9851124,0.00001114289,0.0003985041,0.0003497528,0.01234778,0.00149293,0.0000430473,0.0001428232],"genre_scores_gemma":[0.001493218,0.9845191,0.0003524084,0.0002487321,0.0002482953,0.01229975,0.0001605597,0.000097591,0.0005803718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5638571,"threshold_uncertainty_score":0.9995667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810005278","doi":"10.1016/j.clcc.2018.06.007","title":"Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Colorectal cancer; Disease; Cancer; Internal medicine; Population; Oncology; Disease management; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.03390275452774072,"gpt":0.3805088223531505,"spread":0.3466060678254098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004861588,0.0002328512,0.0007950029,0.0001021287,0.0001282692,0.00002156871,0.00009797641,0.0001200931,0.0001335711],"category_scores_gemma":[0.0003981889,0.0001769358,0.0001620239,0.000285438,0.0003161359,0.000070241,0.00008003598,0.0002864279,0.00000418431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001264195,"about_ca_system_score_gemma":0.0001918503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007284007,"about_ca_topic_score_gemma":0.002115873,"domain_scores_codex":[0.9975719,0.0001771022,0.0009390959,0.0006193062,0.0004393019,0.0002532194],"domain_scores_gemma":[0.9981794,0.0002870702,0.0004402796,0.000291481,0.0004411169,0.0003606664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02864463,0.001205502,0.9446818,0.00008348673,0.0003386592,0.000008937179,0.00003528931,0.000001264891,7.401098e-7,0.000003938102,0.0001151371,0.02488058],"study_design_scores_gemma":[0.006986577,0.01247481,0.9787341,0.0001733107,0.0008323775,2.894232e-7,0.0000295325,0.0004006614,0.000007922715,0.000008499616,0.0001633399,0.0001885713],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966466,0.000097755,0.00003761991,0.0001929191,0.001212237,0.001484819,0.000111545,0.00008028925,0.0001361662],"genre_scores_gemma":[0.9984318,0.00006061837,0.0001659924,0.0004229299,0.000434441,0.0002534799,0.00004112618,0.00003471223,0.0001549244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03405228,"threshold_uncertainty_score":0.7215235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2274727813","doi":"10.1016/j.clcc.2016.02.003","title":"PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium","year":2016,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; University of Ottawa; BC Cancer Agency; Dr. H. Bliss Murphy Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Colorectal cancer; Internal medicine; Confidence interval; Multivariate analysis; Subgroup analysis; Univariate analysis; Oncology; Cancer; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.08771738755791561,"gpt":0.4356488344237635,"spread":0.3479314468658479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001985459,0.0005393107,0.001497852,0.00006340776,0.0002728244,0.00006522473,0.0003786945,0.0006219681,0.001335323],"category_scores_gemma":[0.007701163,0.0002715816,0.0007917104,0.000385319,0.00174663,0.0001576424,0.0002480172,0.0009249895,0.0001901647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001048203,"about_ca_system_score_gemma":0.002188248,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.09552587,"about_ca_topic_score_gemma":0.3543918,"domain_scores_codex":[0.9940406,0.000626134,0.002082314,0.001733754,0.0006034037,0.0009138064],"domain_scores_gemma":[0.9878439,0.009068003,0.0004574826,0.0009109743,0.0003721936,0.001347483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006649292,0.000283977,0.8880585,0.000008469601,0.0007196926,0.00009856748,0.00005719316,1.056814e-7,0.00004972584,0.00002267226,0.006275063,0.09777669],"study_design_scores_gemma":[0.009784915,0.001383007,0.9584439,0.0002772918,0.00053513,0.00001212811,0.00003053299,0.00001700649,0.0002094416,0.0003683381,0.028552,0.00038634],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605415,0.001769542,0.000003443705,0.0270463,0.002858553,0.001932563,0.002159146,0.0001597233,0.003529249],"genre_scores_gemma":[0.9864297,0.005584824,0.0001236827,0.004517834,0.001475869,0.0004747157,0.00003580518,0.00006643457,0.001291158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2588659,"threshold_uncertainty_score":0.9999737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2134613935","doi":"10.1016/j.clcc.2015.06.001","title":"Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Ottawa Hospital; University of Ottawa; Dr. H. Bliss Murphy Cancer Centre; University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Hazard ratio; Odds ratio; Carcinoembryonic antigen; Cancer; Neoadjuvant therapy; Confidence interval; Oncology; Retrospective cohort study; Gastroenterology; Breast cancer; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1689057798124185,"gpt":0.4444205180131557,"spread":0.2755147382007372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001176699,0.0004999068,0.001581947,0.0001387814,0.00006972748,0.00001987691,0.0001958658,0.0002804157,0.0003053572],"category_scores_gemma":[0.001186093,0.0003547814,0.000716844,0.000369862,0.0004124117,0.00009376286,0.0001522807,0.0002921063,0.0000242311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001383882,"about_ca_system_score_gemma":0.0009983376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005334651,"about_ca_topic_score_gemma":0.0009813752,"domain_scores_codex":[0.99581,0.0006734189,0.00132303,0.0009913065,0.0005782383,0.0006240271],"domain_scores_gemma":[0.9963101,0.001426735,0.0004043808,0.00048435,0.0006305013,0.0007439006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1983893,0.00419778,0.7836447,0.00003950005,0.0008264838,0.0003832178,0.001166826,0.00001966852,0.0003679449,8.912704e-7,0.000556142,0.0104075],"study_design_scores_gemma":[0.0310245,0.05357793,0.9023982,0.0001912816,0.001215069,0.00001927458,0.0005213221,0.0004140163,0.001028097,0.0000192359,0.009226723,0.00036438],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884529,0.002096245,0.00001072447,0.0006926191,0.002245574,0.005233819,0.0009151127,0.0001333324,0.0002196977],"genre_scores_gemma":[0.9913592,0.0002935652,0.0003443185,0.0003302535,0.0006197364,0.006376272,0.00003542973,0.00007396346,0.0005673122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1673649,"threshold_uncertainty_score":0.9998904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2602148888","doi":"10.1016/j.clcc.2017.03.008","title":"Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Hazard ratio; Colorectal cancer; Internal medicine; Proportional hazards model; Hematochezia; Cancer; Incidence (geometry); Population; Confidence interval; Colonoscopy","retraction":null,"screen_n_in":null,"score":{"opus":0.08851394996833664,"gpt":0.4440519863351202,"spread":0.3555380363667836,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00142406,0.0003383149,0.00144523,0.0001102618,0.0004042504,0.0001679096,0.0003149616,0.0003078543,0.00008701537],"category_scores_gemma":[0.001966359,0.0002939048,0.0001762113,0.0001323828,0.001099716,0.0003439916,0.0003823737,0.0007553379,0.000002963476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001339014,"about_ca_system_score_gemma":0.0004380647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001662749,"about_ca_topic_score_gemma":0.008340464,"domain_scores_codex":[0.9967772,0.0003298653,0.001290967,0.0008377847,0.0004427068,0.0003215195],"domain_scores_gemma":[0.9969432,0.0006480546,0.0009393085,0.0004212346,0.0006046162,0.0004435877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01635658,0.0007196539,0.9606102,0.0000321255,0.0006157071,0.00003457755,0.0005056969,0.000001451579,0.00005573162,0.000004221027,0.0001039511,0.02096008],"study_design_scores_gemma":[0.005401616,0.008902064,0.9817239,0.0001215512,0.0004244815,0.00002909836,0.0004033172,0.002287481,0.0001921026,0.00002269189,0.0001934531,0.000298257],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994192,0.0002411459,0.000006999454,0.0005169515,0.003116582,0.001007954,0.0003570323,0.00007923926,0.0004820671],"genre_scores_gemma":[0.9972185,0.001466157,0.0001480582,0.0001711944,0.0006003414,0.0001938224,0.00003474611,0.00003871864,0.0001284245],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02111366,"threshold_uncertainty_score":0.9999513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3132399336","doi":"10.1016/j.clcc.2021.02.003","title":"The Landscape of PIK3CA Mutations in Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Colorectal cancer; Medicine; P110α; Cancer research; Mutation; Cancer; Mouse model of colorectal and intestinal cancer; Wnt signaling pathway; Targeted therapy; Oncology; Disease; Gene; Internal medicine; Biology; Genetics; Protein subunit","retraction":null,"screen_n_in":null,"score":{"opus":0.02790282534814936,"gpt":0.3666921568710767,"spread":0.3387893315229273,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005010411,0.0001709902,0.0003141846,0.00002709563,0.0001084538,0.00002604585,0.0003020211,0.0002718811,0.0002609104],"category_scores_gemma":[0.0007825022,0.0001392695,0.000221468,0.0003329103,0.0003799819,0.00000549358,0.000165918,0.0003083325,0.000006782861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006215424,"about_ca_system_score_gemma":0.00110809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001429012,"about_ca_topic_score_gemma":0.007279886,"domain_scores_codex":[0.9980828,0.0002346122,0.000643491,0.0004844743,0.0002129098,0.0003417234],"domain_scores_gemma":[0.9987408,0.0003733109,0.0002114286,0.0002439002,0.0003269898,0.000103603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00158144,0.0003266695,0.5305879,0.00005078677,0.0003443346,0.00002922528,0.0001419589,0.00145372,0.429717,0.0001687086,0.01239308,0.02320517],"study_design_scores_gemma":[0.002487582,0.00104685,0.3040771,0.0001260542,0.00009993628,0.00001291718,0.0002485519,0.000583561,0.6495706,0.000315814,0.04095355,0.0004774433],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865596,0.009407246,0.00002325292,0.0007865929,0.001402115,0.0002061029,0.0001273846,0.00001208229,0.001475577],"genre_scores_gemma":[0.9946588,0.003502129,0.0000934903,0.0003345091,0.0006422175,0.000290727,0.00005684532,0.00002976519,0.0003914653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2265108,"threshold_uncertainty_score":0.5679246,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2238807295","doi":"10.1016/j.clcc.2015.12.008","title":"Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Discontinuation; Hazard ratio; Lapatinib; Concomitant; Colorectal cancer; Gastroenterology; Stage (stratigraphy); Oncology; Oxaliplatin; Confidence interval; Cancer; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03919548041833396,"gpt":0.3486369122872736,"spread":0.3094414318689396,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006302958,0.0003452384,0.001026577,0.0001090833,0.00008211104,0.00002397769,0.00009209466,0.000246338,0.00007395265],"category_scores_gemma":[0.001291608,0.0002573001,0.0001187429,0.0005304014,0.0005394843,0.0001598214,0.00008639439,0.0005015803,0.000002009463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006886848,"about_ca_system_score_gemma":0.001145956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005574801,"about_ca_topic_score_gemma":0.01560786,"domain_scores_codex":[0.9971824,0.0002488896,0.0009614322,0.000632724,0.0005833208,0.0003911944],"domain_scores_gemma":[0.9976334,0.0004345017,0.0006668905,0.0001432602,0.0007421239,0.0003798416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01596328,0.001169028,0.9770638,0.00006748702,0.0003173839,0.00003991437,0.001063036,0.00000209086,0.0000698142,0.000003046787,0.000223414,0.004017694],"study_design_scores_gemma":[0.01284068,0.01528325,0.9645311,0.0005242348,0.0002481373,0.000002131737,0.0002154837,0.0001795068,0.005566578,0.00002075714,0.0003051658,0.0002829312],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946494,0.0009851997,6.65983e-7,0.0002309554,0.0003474941,0.002487854,0.0007226233,0.00003896823,0.0005369107],"genre_scores_gemma":[0.9975262,0.0009959866,0.00003184587,0.0001221499,0.0001208275,0.00104277,0.00005501851,0.00003348234,0.00007168965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01411423,"threshold_uncertainty_score":0.9999879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792344809","doi":"10.1016/j.clcc.2018.03.001","title":"A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Queen's University; Ottawa Hospital; Saskatchewan Cancer Agency; Western University; University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; McGill University; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Oncolytics Biotech","keywords":"Medicine; Bevacizumab; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.07572923921422868,"gpt":0.439881470559381,"spread":0.3641522313451523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00426281,0.0005608847,0.002595644,0.0002856047,0.0002481008,0.00004793703,0.0005810554,0.0003137279,0.000750085],"category_scores_gemma":[0.001537515,0.0003587018,0.0003236127,0.0007910819,0.001111269,0.00002415046,0.000162731,0.0005138297,0.000003008046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003581159,"about_ca_system_score_gemma":0.004855343,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05658879,"about_ca_topic_score_gemma":0.8934857,"domain_scores_codex":[0.9924421,0.002873788,0.001836238,0.001170125,0.0007897322,0.0008879905],"domain_scores_gemma":[0.996654,0.0005448513,0.0009194393,0.0005110021,0.000815444,0.0005552573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9284705,0.003511925,0.0528807,0.00002870561,0.001916542,0.00001827088,0.0005954452,0.00003623434,0.001016323,0.000001463586,0.0002158244,0.01130809],"study_design_scores_gemma":[0.7824293,0.2038971,0.003366843,0.0001186636,0.0006339073,0.000001516035,0.0002212552,0.0001461079,0.008351691,0.000009545742,0.0002915416,0.0005324431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887099,0.0005951573,0.00001234193,0.0001165551,0.000602128,0.00933283,0.0005437807,0.00001837007,0.0000689177],"genre_scores_gemma":[0.9934568,0.0003066974,0.00009699096,0.0002436808,0.0006828986,0.004884966,0.0001101009,0.0001038459,0.0001139903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.836897,"threshold_uncertainty_score":0.9998865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346804067","doi":"10.1016/j.clcc.2016.04.010","title":"A Practical Approach to Fatigue Management in Colorectal Cancer","year":2016,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Colorectal cancer; Quality of life (healthcare); Cancer; Disease; Intensive care medicine; Cancer-related fatigue; Anemia; Randomized controlled trial; Physical therapy; Palliative care; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.2188126030990678,"gpt":0.5039019339954651,"spread":0.2850893308963973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001168356,0.0008982241,0.004087099,0.0004269698,0.00007519454,0.00005847105,0.0004713415,0.001146531,0.0009528332],"category_scores_gemma":[0.0004549515,0.0006325954,0.001381255,0.001304817,0.0003041605,0.0001050031,0.0004738664,0.001776411,0.0002877751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001916248,"about_ca_system_score_gemma":0.00210696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000694208,"about_ca_topic_score_gemma":0.003691493,"domain_scores_codex":[0.993637,0.0006057071,0.002067411,0.001831028,0.0008298304,0.001028972],"domain_scores_gemma":[0.9968188,0.0009937411,0.0005226902,0.000563384,0.0002075792,0.0008937387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001191827,0.0006588409,0.0007582761,0.009745045,0.0008566062,0.0002268578,0.00009848273,7.289912e-7,4.58824e-7,0.0003512437,0.0163112,0.9698004],"study_design_scores_gemma":[0.001538028,0.0006231057,0.001289024,0.01958597,0.001655274,0.0000547728,0.00006557031,0.00001015647,0.00000334163,0.00001923378,0.9743505,0.0008050028],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005817603,0.959783,0.0001367361,0.0009998409,0.003935589,0.005329299,0.0003415868,0.0001443657,0.02874786],"genre_scores_gemma":[0.0008354278,0.9835589,0.0005405313,0.001030156,0.00218872,0.009695006,0.00009366038,0.000189624,0.001867987],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9689955,"threshold_uncertainty_score":0.9999604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893632802","doi":"10.1016/j.clcc.2018.09.008","title":"Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Proportional hazards model; Oncology; Univariate analysis; Multivariate analysis; Randomized controlled trial; Survival analysis; Progression-free survival; Cancer; Overall survival","retraction":null,"screen_n_in":null,"score":{"opus":0.0960904364251401,"gpt":0.3665235278098591,"spread":0.270433091384719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00572962,0.0003827348,0.004694706,0.0004131712,0.00006587581,0.00001473144,0.0001682314,0.0002148009,0.001453966],"category_scores_gemma":[0.008705759,0.0002377946,0.001919622,0.001576921,0.001561884,0.0000985712,0.00008002055,0.0002534415,0.000009723114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008316867,"about_ca_system_score_gemma":0.0004641007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0010585,"about_ca_topic_score_gemma":0.00095535,"domain_scores_codex":[0.9933499,0.002558908,0.00238998,0.0006332801,0.0006972897,0.0003706985],"domain_scores_gemma":[0.9892392,0.007309498,0.001410846,0.0003412337,0.001366412,0.0003327955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.157535,0.001352194,0.8209909,0.00008674383,0.01637743,0.00002742607,0.000149318,0.000007485761,0.0001079195,0.00003108739,0.000116036,0.00321843],"study_design_scores_gemma":[0.1536491,0.006057693,0.7235227,0.000335502,0.0904124,0.000001086599,0.00001952812,0.01894346,0.006747327,0.0000206414,0.0000225074,0.0002680286],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937744,0.0009441861,0.0002840706,0.00005976958,0.0002373289,0.003993758,0.0004511027,0.00004201155,0.0002133406],"genre_scores_gemma":[0.9971654,0.0001502816,0.001245921,0.0001238758,0.0002650344,0.00050336,0.0004634004,0.00004190157,0.00004081304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0974682,"threshold_uncertainty_score":0.9996443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2180532331","doi":"10.1016/j.clcc.2015.09.002","title":"Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Medicine; Capecitabine; FOLFOX; Oxaliplatin; Internal medicine; Colorectal cancer; Cancer; Stage (stratigraphy); Proportional hazards model; Chemotherapy; Population; Oncology; Multivariate analysis","retraction":null,"screen_n_in":null,"score":{"opus":0.07931558617590619,"gpt":0.4048498885343196,"spread":0.3255343023584134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004552938,0.0003103309,0.001160278,0.0001032699,0.00003700286,0.00001150596,0.0001615353,0.0002694718,0.0002410035],"category_scores_gemma":[0.0003341493,0.0002301919,0.0002364591,0.0005016828,0.0003223994,0.0001068456,0.00005313654,0.0003369917,0.000005211011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000838888,"about_ca_system_score_gemma":0.001253631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001299572,"about_ca_topic_score_gemma":0.005723902,"domain_scores_codex":[0.9974489,0.0001044066,0.0008217662,0.0006227707,0.0005201636,0.0004820322],"domain_scores_gemma":[0.9977301,0.0005432849,0.0003626603,0.0002919217,0.00060498,0.0004670153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04751805,0.001712649,0.9206181,0.00009999984,0.0002877128,0.00001962414,0.0002375545,0.00004531067,0.00004032678,0.00003078839,0.001560166,0.02782968],"study_design_scores_gemma":[0.04729396,0.01460785,0.9241503,0.000432697,0.0002276025,0.000001446,0.0001060621,0.0002026607,0.001102503,0.00008854074,0.01145428,0.0003320731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935737,0.0009906207,0.00002507266,0.0008914673,0.000556116,0.002553791,0.0003068695,0.00005484069,0.001047502],"genre_scores_gemma":[0.9964042,0.0003953276,0.0004169299,0.0005980876,0.0001778725,0.001152553,0.00005953456,0.00006663914,0.0007288071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0274976,"threshold_uncertainty_score":0.9386954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901835434","doi":"10.1016/j.clcc.2018.11.001","title":"Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; Alberta Cancer Foundation","funders":"","keywords":"Oxaliplatin; FOLFOX; Capecitabine; Medicine; Internal medicine; Colorectal cancer; Oncology; Hazard ratio; Chemotherapy; Confidence interval; Cancer; Stage (stratigraphy); Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.02223263260945117,"gpt":0.3807895616378186,"spread":0.3585569290283674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003532201,0.0001917064,0.0003505653,0.0000603829,0.000062958,0.00001276594,0.0001638387,0.000321466,0.0000608859],"category_scores_gemma":[0.0005231695,0.0001637944,0.0001199379,0.0001831514,0.0006556861,0.000006055299,0.0001837611,0.000270242,0.000008343285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004787984,"about_ca_system_score_gemma":0.0002792895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003642653,"about_ca_topic_score_gemma":0.001185057,"domain_scores_codex":[0.9982376,0.0001999671,0.0004195122,0.0005618859,0.000212518,0.0003685654],"domain_scores_gemma":[0.9992041,0.0002138756,0.000135447,0.0001478975,0.0001353273,0.0001633406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003135304,0.000352967,0.2035911,0.0001732438,0.00009853105,0.00001909152,0.00007212439,0.000003801423,0.7814237,0.00001814898,0.001480607,0.009631313],"study_design_scores_gemma":[0.001444615,0.003886476,0.1492097,0.0001683477,0.00001972827,9.574023e-7,0.0000170032,0.00005275881,0.8418823,0.00002183284,0.003112396,0.0001838389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968393,0.0009836626,0.000003036944,0.0002198945,0.0003697934,0.001015912,0.00003023419,0.00001006358,0.0005281061],"genre_scores_gemma":[0.996521,0.001547233,0.00002186147,0.0002325925,0.0008964681,0.0005870642,0.000009904667,0.00002938713,0.0001544708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06045858,"threshold_uncertainty_score":0.6679344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019925885","doi":"10.1016/j.clcc.2013.12.002","title":"Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147","year":2014,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"FOLFIRI; Medicine; Cetuximab; Irinotecan; KRAS; Colorectal cancer; Internal medicine; Oncology; FOLFOX; Clinical endpoint; Hazard ratio; Randomized controlled trial; Cancer; Surgery; Oxaliplatin; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.06875470791630059,"gpt":0.4297178547705361,"spread":0.3609631468542355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000437766,0.0004740167,0.002312475,0.0001171075,0.0001175902,0.00002477977,0.0002316174,0.0002555357,0.0004211074],"category_scores_gemma":[0.0003509458,0.0002835288,0.0001844437,0.0007004988,0.0006337006,0.0001272825,0.0001279658,0.0006680413,0.000004339806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006093953,"about_ca_system_score_gemma":0.0006848974,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00187989,"about_ca_topic_score_gemma":0.05280071,"domain_scores_codex":[0.9962478,0.0002424878,0.001313792,0.0008519405,0.0007452645,0.0005986853],"domain_scores_gemma":[0.9974787,0.0006043036,0.0007025356,0.0003877592,0.0005537781,0.0002728711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3855565,0.00196172,0.6034093,0.0001099486,0.0003839878,0.000008868938,0.0003594358,0.00002188457,0.00002588148,0.000009242393,0.000500195,0.007653024],"study_design_scores_gemma":[0.1848101,0.06323745,0.7454749,0.0009928229,0.0004602607,7.75946e-7,0.0002362874,0.0005310551,0.0006266565,0.000005313398,0.003215793,0.0004086241],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938639,0.0005267428,0.0000240029,0.0003162993,0.000718269,0.002901908,0.00008973571,0.00007293988,0.001486251],"genre_scores_gemma":[0.9969993,0.0002661404,0.0002576453,0.0002616422,0.0003466046,0.0009366652,0.00004401418,0.00006750061,0.0008204782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2007464,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984077136","doi":"10.3816/ccc.2003.n.022","title":"Systematic Review of Management of Colorectal Cancer in Elderly Patients","year":2003,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Guideline; Internal medicine; Oncology; Cochrane Library; Clinical trial; MEDLINE; Randomized controlled trial; Adjuvant therapy; Radiation therapy; Cancer; Intensive care medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0693949226393203,"gpt":0.4369303317551795,"spread":0.3675354091158592,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001425551,0.0009917822,0.01175995,0.0003332516,0.00003461727,0.000009795294,0.0005564121,0.0007921947,0.001201132],"category_scores_gemma":[0.0006072061,0.0007285075,0.002695937,0.00193901,0.0004041732,0.00007839235,0.0002582025,0.001013505,0.0000407252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00154458,"about_ca_system_score_gemma":0.001230505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001198801,"about_ca_topic_score_gemma":0.0001128501,"domain_scores_codex":[0.989661,0.001117361,0.006133593,0.001203868,0.001194904,0.0006892197],"domain_scores_gemma":[0.9939765,0.001147246,0.003151587,0.0007286363,0.0006054972,0.0003905365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003965086,0.001257239,0.003139996,0.8129631,0.002520584,0.00008838462,0.00001110213,2.768233e-7,6.737707e-8,0.00002190176,0.0002606704,0.1793402],"study_design_scores_gemma":[0.002952158,0.002437836,0.003160868,0.9505045,0.01488562,0.00001412712,0.000008694589,0.000002217071,0.00000567479,0.000009783756,0.02544844,0.0005700715],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003697451,0.97865,5.255463e-7,0.0000245114,0.001375617,0.01223302,0.0005347324,0.00003861213,0.003445558],"genre_scores_gemma":[0.0008660349,0.9919531,0.00009932989,0.0001502294,0.00007205717,0.006182456,0.000132076,0.0001399988,0.0004047256],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1787701,"threshold_uncertainty_score":0.9997119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2723787463","doi":"10.1016/j.clcc.2017.06.001","title":"Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II Trial","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Jiangsu National Synergistic Innovation Center for Advanced Materials","keywords":"Medicine; Colorectal cancer; Confidence interval; Randomized controlled trial; Adverse effect; Aerobic exercise; Internal medicine; Cancer; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.0390012946704929,"gpt":0.4099210775514048,"spread":0.3709197828809119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003297026,0.000438702,0.002806776,0.0001324607,0.0004293724,0.00006404654,0.0005112538,0.0005446869,0.0007447176],"category_scores_gemma":[0.006026187,0.0003494957,0.001336985,0.0002138773,0.001811683,0.0002005271,0.0002865208,0.0007126826,0.00001263508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002218207,"about_ca_system_score_gemma":0.00105453,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01785821,"about_ca_topic_score_gemma":0.02374315,"domain_scores_codex":[0.9956402,0.0009794609,0.001418364,0.000775505,0.0006231173,0.0005633911],"domain_scores_gemma":[0.9935337,0.003395437,0.001147673,0.0009450131,0.0004466057,0.0005315635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.958927,0.001563483,0.008932559,0.0003701032,0.0004598995,0.00009476695,0.0007376316,0.000002905067,0.002180403,0.00001199986,0.001113464,0.0256058],"study_design_scores_gemma":[0.9340448,0.009645679,0.03090731,0.001791335,0.001967125,0.000002604573,0.00006396146,0.000229408,0.01829937,0.00005603543,0.002506954,0.0004854033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803039,0.003776187,0.00001119824,0.0009193398,0.009449639,0.004876895,0.00007369013,0.0000981934,0.0004909292],"genre_scores_gemma":[0.9905324,0.002896176,0.00001952676,0.0002856293,0.001394368,0.00287624,0.00001556704,0.00007218408,0.001907919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0251204,"threshold_uncertainty_score":0.9998957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081037798","doi":"10.3816/ccc.2007.n.014","title":"Hypoxia-Induced Lactate Dehydrogenase Expression and Tumor Angiogenesis","year":2007,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Angiogenesis; Medicine; Colorectal cancer; Hypoxia (environmental); Cancer; Cancer research; Oncology; Clinical trial; HIF1A; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0846031284535441,"gpt":0.4099892040546416,"spread":0.3253860756010974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007678082,0.0006524224,0.00177815,0.000114998,0.0001349989,0.00004545132,0.0003883133,0.0009577672,0.00007787599],"category_scores_gemma":[0.0003526341,0.0005365704,0.00109917,0.0002448775,0.0002407176,0.000006775594,0.0003823219,0.0004849355,0.00002926309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005402297,"about_ca_system_score_gemma":0.0007622464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004534071,"about_ca_topic_score_gemma":0.0001621583,"domain_scores_codex":[0.9964333,0.000331291,0.001135001,0.001235596,0.0002519663,0.0006128898],"domain_scores_gemma":[0.9980878,0.0001869879,0.0005691429,0.0005241829,0.0001279797,0.0005038821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002773302,0.0001085659,0.00005149475,0.001432807,0.0002798316,0.00001664491,0.000007393562,2.881517e-7,0.008962502,0.00000289596,0.005885645,0.9829746],"study_design_scores_gemma":[0.00067521,0.0003386055,0.0001268465,0.001167498,0.0007134678,0.00005900645,0.000005668011,0.000001272518,0.005419082,0.000006007014,0.9908143,0.0006730491],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06187987,0.9334483,0.00001004252,0.00001070963,0.003319268,0.0007909252,0.0002202757,0.00003417526,0.0002864421],"genre_scores_gemma":[0.001285951,0.9902484,0.0001568627,0.0003558111,0.006876728,0.0003347326,0.0001988998,0.0001351788,0.0004074112],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849287,"threshold_uncertainty_score":0.9997086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024511775","doi":"10.3816/ccc.2005.n.005","title":"5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study","year":2005,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Colorectal cancer; Tolerability; Chemotherapy; Fluorouracil; Stomatitis; Cancer; Diarrhea; Toxicity; Performance status; Oncology; Gastroenterology; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.03427233539537161,"gpt":0.3795017176338492,"spread":0.3452293822384776,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002530345,0.0008192332,0.001789907,0.0001829686,0.0002814076,0.00004959161,0.000244515,0.0002737185,0.0007713443],"category_scores_gemma":[0.0001569267,0.0006357708,0.0006964774,0.0006447695,0.0002659364,0.0002311133,0.00006646859,0.0004483243,0.000009567783],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004033393,"about_ca_system_score_gemma":0.0009960072,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002677436,"about_ca_topic_score_gemma":0.175093,"domain_scores_codex":[0.9951148,0.0001724349,0.001430155,0.00143376,0.0005855337,0.001263319],"domain_scores_gemma":[0.9976981,0.0005583565,0.0004343329,0.0003425972,0.0004598634,0.0005067813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01904382,0.007013426,0.6123303,0.00004472024,0.0006836089,0.00001756192,0.000850072,0.0003183936,0.00007257149,0.000002340103,0.0004633062,0.3591599],"study_design_scores_gemma":[0.0475082,0.02656093,0.9087793,0.0001770813,0.0006185559,0.000001058878,0.0002998045,0.0009814027,0.0007269566,0.000006953911,0.01370595,0.0006337971],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828038,0.003951948,0.00001187836,0.002792664,0.001413316,0.007790547,0.0008252101,0.0001619106,0.0002487373],"genre_scores_gemma":[0.9787408,0.003605581,0.0003254858,0.001289071,0.001260614,0.01417449,0.000120334,0.0001248046,0.0003587809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3585261,"threshold_uncertainty_score":0.99979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2148590676","doi":"10.1016/j.clcc.2013.04.004","title":"The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database","year":2013,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Predictive value; Colorectal cancer; Stress (linguistics); Oncology; Stage (stratigraphy); Internal medicine; Pooled analysis; Value (mathematics); Database; Cancer; Meta-analysis; Statistics; Linguistics; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.03001006439902859,"gpt":0.355657160752562,"spread":0.3256470963535334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103029,0.0002542597,0.001009695,0.0000905621,0.00009253896,0.00002544746,0.0002768155,0.0001656095,0.0003608723],"category_scores_gemma":[0.001173692,0.0001428021,0.0003054916,0.001053057,0.0007000956,0.0001140461,0.0002939465,0.0004463202,0.000003578068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002875652,"about_ca_system_score_gemma":0.0003271522,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02313195,"about_ca_topic_score_gemma":0.008657216,"domain_scores_codex":[0.9969898,0.0004327684,0.001074959,0.000565635,0.0005719615,0.0003648738],"domain_scores_gemma":[0.9942132,0.004267703,0.0005081084,0.0004280157,0.0003633916,0.0002196088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003622146,0.0006391639,0.9800509,0.0000300561,0.002581422,0.000006720571,0.0005495432,0.00006292862,0.0001040676,0.00001279949,0.0001531147,0.01218714],"study_design_scores_gemma":[0.003534392,0.001711869,0.9853172,0.0001969253,0.002836267,1.698381e-7,0.0001691276,0.005175462,0.0006027421,0.00003821009,0.0002895804,0.0001280382],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931521,0.001832963,0.000003122233,0.0005511447,0.0003038573,0.002414804,0.001492203,0.00001903912,0.0002307048],"genre_scores_gemma":[0.9961346,0.002189646,0.00002688388,0.0002444459,0.00009320157,0.001106417,0.00009713494,0.00002302301,0.00008469117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01447473,"threshold_uncertainty_score":0.9833731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2335069544","doi":"10.1016/j.clcc.2016.03.004","title":"A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cetuximab; Medicine; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Phosphatidylinositol; Kinase; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03115746277251978,"gpt":0.3507161003024449,"spread":0.3195586375299251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001067189,0.0004689317,0.001439741,0.0001049408,0.0001036147,0.00002365846,0.0003953003,0.0002873875,0.0001797134],"category_scores_gemma":[0.0006002033,0.0002673388,0.0002653339,0.0003458555,0.00100341,0.00004619634,0.0001616062,0.0002693464,0.00000320358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001440185,"about_ca_system_score_gemma":0.001305154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002563391,"about_ca_topic_score_gemma":0.001505789,"domain_scores_codex":[0.9961292,0.0006879047,0.001129811,0.0009649508,0.0005262724,0.0005618575],"domain_scores_gemma":[0.9977831,0.0003605952,0.0006606814,0.0004497942,0.0004410309,0.0003047686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8902742,0.00341602,0.09481941,0.00004037709,0.0003357078,0.00001979765,0.00008988622,0.0000168407,0.005667215,0.000006254576,0.000275828,0.005038514],"study_design_scores_gemma":[0.8392576,0.05998086,0.003427244,0.0002151759,0.0003768021,0.000003830185,0.00003621081,0.0001092124,0.09556294,0.00001582533,0.00045324,0.0005610786],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958971,0.0002930204,0.000157036,0.00007532283,0.0006864308,0.002572536,0.0002151866,0.00002526009,0.00007814769],"genre_scores_gemma":[0.9974227,0.00007616291,0.001006622,0.0001482259,0.0003663444,0.000652604,0.00008427395,0.000077809,0.0001652711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09139217,"threshold_uncertainty_score":0.9999779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604055952","doi":"10.1016/j.clcc.2017.03.013","title":"Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Oncology; Internal medicine; Neurotoxicity; Adjuvant; Cohort; Population; Cancer; Toxicity; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.05068831074772731,"gpt":0.416747593082448,"spread":0.3660592823347207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245549,0.0002855421,0.001138052,0.00009676605,0.000155479,0.00001926024,0.0001797807,0.0002257647,0.0003030629],"category_scores_gemma":[0.0003959542,0.000210544,0.0002704461,0.0001213986,0.0002687453,0.00009528985,0.00003689694,0.000280696,0.000001900163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003223902,"about_ca_system_score_gemma":0.000485741,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007722595,"about_ca_topic_score_gemma":0.01936712,"domain_scores_codex":[0.9979365,0.00009663436,0.000787606,0.0005342787,0.0002786714,0.0003662351],"domain_scores_gemma":[0.9979559,0.0006626453,0.000633246,0.0002528703,0.000303697,0.0001916453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01528504,0.00137861,0.9770117,0.00009113896,0.0003032956,0.00001342233,0.00002634322,0.00004638045,0.0003808341,0.000006422863,0.0002561756,0.005200596],"study_design_scores_gemma":[0.01807622,0.006710415,0.9698585,0.0001556811,0.0005093856,6.356601e-7,0.000002962671,0.0008627222,0.003460289,0.00001231211,0.0001366261,0.0002142462],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994508,0.000073812,0.000003676083,0.0006920028,0.0005449687,0.003421237,0.0004885907,0.00003763537,0.0002301215],"genre_scores_gemma":[0.9968768,0.0000576435,0.00009323646,0.0003823408,0.0001560799,0.002059688,0.0001554222,0.00004223581,0.0001765741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01164452,"threshold_uncertainty_score":0.9988851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965195516","doi":"10.1016/j.clcc.2011.06.004","title":"The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status","year":2011,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"Amgen","keywords":"Panitumumab; Medicine; Irinotecan; FOLFIRI; Colorectal cancer; Oncology; Internal medicine; Toxicity; Cetuximab; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.0947725036192167,"gpt":0.4069263352868261,"spread":0.3121538316676094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00128692,0.0005190106,0.001543754,0.000100549,0.0003825133,0.000052245,0.0002530556,0.0001511794,0.000884613],"category_scores_gemma":[0.0003314562,0.0002382646,0.0002671813,0.0008051516,0.001111834,0.0001239397,0.0000908502,0.0005124962,6.644337e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000497673,"about_ca_system_score_gemma":0.002028666,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002982258,"about_ca_topic_score_gemma":0.1532296,"domain_scores_codex":[0.995997,0.0005934378,0.001330095,0.0008515138,0.000627509,0.0006004886],"domain_scores_gemma":[0.9943771,0.003523132,0.0008392078,0.0004061252,0.0006176065,0.0002368807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4560141,0.002391576,0.2656938,0.0001608719,0.01271903,0.00002930535,0.003973531,0.00002291155,0.0005376099,0.00001997471,0.0004757701,0.2579616],"study_design_scores_gemma":[0.04435894,0.03240946,0.9059034,0.0002034184,0.003741226,0.000006869152,0.001585668,0.001073237,0.005715658,0.00007587019,0.004500181,0.0004260844],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9462829,0.001946673,0.00004709873,0.0003628299,0.0001180594,0.04936881,0.001456629,0.00003153359,0.0003855008],"genre_scores_gemma":[0.9258764,0.000842639,0.0002710309,0.0003058489,0.00009530364,0.0723694,0.00008799815,0.00005241978,0.0000989705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6402096,"threshold_uncertainty_score":0.9716149,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003910285","doi":"10.3816/ccc.2005.n.040","title":"Outcomes in Elderly Patients with Advanced Colorectal Cancer Treated with Capecitabine: A Population-Based Analysis","year":2005,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Capecitabine; Internal medicine; Cohort; Oxaliplatin; Colorectal cancer; Irinotecan; Population; Cancer; Cancer registry; Oncology; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01785857122627238,"gpt":0.3439939985697646,"spread":0.3261354273434922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001630155,0.0005597247,0.00172942,0.0003657147,0.0001639385,0.00003337174,0.0001428794,0.0002161507,0.0008318062],"category_scores_gemma":[0.0001323319,0.0003541444,0.000396595,0.0018117,0.0002325166,0.00018749,0.00003983748,0.0004486501,0.00001288756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001182229,"about_ca_system_score_gemma":0.000457868,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003835966,"about_ca_topic_score_gemma":0.09371685,"domain_scores_codex":[0.9966784,0.0001130156,0.0009330648,0.0009616191,0.0006638092,0.0006500952],"domain_scores_gemma":[0.9980915,0.0004599029,0.0003606255,0.0002877533,0.0004762764,0.0003240098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01499231,0.001622042,0.9479439,0.00002868058,0.002268854,0.00003171891,0.00007905729,0.002451863,0.00001068044,0.000003011286,0.00007354331,0.03049435],"study_design_scores_gemma":[0.01613483,0.006087082,0.9734318,0.0001426,0.002193008,8.535376e-7,0.00004395698,0.0009795782,0.0001359688,0.000002005322,0.0003786948,0.000469605],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952931,0.0006465442,0.000008828586,0.001311646,0.0001384274,0.001620064,0.0002257244,0.0001304937,0.0006252199],"genre_scores_gemma":[0.9963336,0.0001553413,0.0005933409,0.0006559468,0.0001464386,0.001462155,0.0002397803,0.00006486395,0.0003485146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08988089,"threshold_uncertainty_score":0.999891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898880167","doi":"10.1016/j.clcc.2018.10.006","title":"5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Colorectal cancer; Internal medicine; Logistic regression; Cardiotoxicity; Fluorouracil; Oncology; Univariate analysis; Multivariate analysis; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.06564236374605982,"gpt":0.4145528139470809,"spread":0.3489104502010211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001748832,0.000715696,0.004451502,0.0002911126,0.000231233,0.00002711722,0.0002755643,0.0003590241,0.001126612],"category_scores_gemma":[0.003193145,0.00053318,0.001177981,0.001009147,0.002922995,0.0001622552,0.0002227166,0.0007789783,0.00003160072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098113,"about_ca_system_score_gemma":0.001044721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004905766,"about_ca_topic_score_gemma":0.00696702,"domain_scores_codex":[0.9939997,0.0008743263,0.002340904,0.001181313,0.0007983896,0.0008054034],"domain_scores_gemma":[0.9927508,0.004690873,0.00075252,0.0003905956,0.001090646,0.0003245912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4407801,0.002387157,0.4997085,0.0004852434,0.01998939,0.0004962847,0.009099968,0.0008708685,0.003922916,0.0001088461,0.005248311,0.01690245],"study_design_scores_gemma":[0.4366015,0.01391344,0.4618718,0.003745689,0.009739804,0.00002984269,0.003477266,0.01063959,0.05577738,0.00111971,0.001029511,0.00205444],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973677,0.01800737,0.00002008678,0.001793032,0.001789824,0.002816977,0.000449915,0.0001217416,0.001323994],"genre_scores_gemma":[0.9910867,0.00470259,0.0008107973,0.0006297053,0.0004395788,0.001752472,0.00005460423,0.00007807757,0.0004454391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05185446,"threshold_uncertainty_score":0.9997905,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2907344428","doi":"10.1016/j.clcc.2018.12.006","title":"Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Folinic acid; Oxaliplatin; Colorectal cancer; Nausea; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04981833589082255,"gpt":0.4204086447227027,"spread":0.3705903088318802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001827254,0.0004235782,0.005663181,0.0003034733,0.00009711191,0.00001548082,0.0001148838,0.0001492331,0.0008009096],"category_scores_gemma":[0.002075917,0.000238026,0.001603885,0.001032852,0.001760845,0.00006448791,0.00005600555,0.0002334774,0.000001030367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002804146,"about_ca_system_score_gemma":0.0003797709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001837088,"about_ca_topic_score_gemma":0.001578411,"domain_scores_codex":[0.9959692,0.0007433639,0.001750554,0.0006208695,0.0005603236,0.000355661],"domain_scores_gemma":[0.9932635,0.004211279,0.001281245,0.0002433556,0.0007443256,0.0002562445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3074044,0.001762843,0.6346091,0.00003425565,0.03622359,0.000002681389,0.0005278559,0.00002832473,0.0001916907,0.00000387073,0.0001168195,0.01909462],"study_design_scores_gemma":[0.1522198,0.01343521,0.81354,0.0001504725,0.01699086,3.389331e-7,0.0000337331,0.0005196323,0.002893817,0.00001142858,0.000008588866,0.0001960432],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954367,0.0007948084,0.00001148165,0.0001205918,0.000194044,0.002549408,0.0004380438,0.00003083103,0.0004240493],"genre_scores_gemma":[0.997942,0.001197319,0.00009867953,0.0001426417,0.0001635403,0.0003272667,0.00003964494,0.00003508689,0.00005387164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1789309,"threshold_uncertainty_score":0.9706417,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021254114","doi":"10.1016/j.clcc.2013.06.005","title":"Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance","year":2013,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Colorectal cancer; Internal medicine; Hazard ratio; Cancer; Body mass index; Confidence interval; Regimen; Statistical significance; Prospective cohort study; Oncology; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.03165009080649418,"gpt":0.372343720235396,"spread":0.3406936294289018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001664713,0.0004443369,0.00126073,0.00007884939,0.00004532065,0.00002706522,0.0002095328,0.0002855488,0.002579725],"category_scores_gemma":[0.0001689275,0.000321365,0.0004770449,0.0005339285,0.0003272923,0.0001912912,0.00009249616,0.0009108749,0.00002949387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001260819,"about_ca_system_score_gemma":0.0006626493,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06598057,"about_ca_topic_score_gemma":0.05545325,"domain_scores_codex":[0.9970882,0.0002085742,0.0005401284,0.000857271,0.0007171794,0.0005886346],"domain_scores_gemma":[0.997702,0.000810126,0.0002928908,0.0003720944,0.0004212227,0.0004016727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01567891,0.002092577,0.9205986,0.000071989,0.0002751015,0.000007990404,0.0003602245,0.00003607669,0.00007874866,0.000001463609,0.001461286,0.05933705],"study_design_scores_gemma":[0.004644241,0.005144553,0.9871673,0.001037658,0.0001880875,7.950698e-8,0.00001890003,0.0001760778,0.0008800371,0.00001378154,0.0003506753,0.0003786106],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945341,0.0006703042,9.682915e-7,0.0005463684,0.001321084,0.001363177,0.001409899,0.00003895978,0.0001151704],"genre_scores_gemma":[0.9920342,0.0009764141,0.000006978393,0.0002605602,0.0005744554,0.005991329,0.00003964512,0.00006115429,0.00005529196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06656872,"threshold_uncertainty_score":0.9999238,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988566656","doi":"10.3816/ccc.2009.n.023","title":"Comparison of Treatment Received Versus Long-Standing Guidelines for Stage III Colon and Stage II/III Rectal Cancer Patients Diagnosed in Alberta, Saskatchewan, and Manitoba in 2004","year":2009,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"CancerCare Manitoba; Saskatchewan Cancer Agency; Alberta Cancer Foundation","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Stage (stratigraphy); Colorectal cancer; General surgery; Internal medicine; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1456539180038615,"gpt":0.4636673713705664,"spread":0.3180134533667048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004237673,0.0004816796,0.001773901,0.0002011827,0.000113958,0.0000230408,0.0001138775,0.0003732859,0.0001440703],"category_scores_gemma":[0.0008607583,0.0004099623,0.0002174154,0.0004372785,0.0002674673,0.0001449795,0.00009054434,0.0003411694,7.078247e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002053749,"about_ca_system_score_gemma":0.0005864052,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02367919,"about_ca_topic_score_gemma":0.3956378,"domain_scores_codex":[0.9963298,0.0001438524,0.001673401,0.00091266,0.0003337997,0.0006064938],"domain_scores_gemma":[0.9968244,0.001740666,0.0005083737,0.0002197798,0.0003590893,0.0003477186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04734773,0.001709524,0.9010341,0.00008929585,0.0001984833,0.00004249991,0.001606149,0.000115363,0.0001758684,0.000005588899,0.0003068733,0.04736858],"study_design_scores_gemma":[0.06357235,0.02694649,0.9011575,0.0007157815,0.0003108898,0.000001220126,0.001332454,0.001562874,0.002214248,0.0000245488,0.001688889,0.0004727597],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916157,0.003264274,0.000003726145,0.0007401539,0.0007593262,0.00307403,0.0002430655,0.00003239084,0.0002673627],"genre_scores_gemma":[0.9952349,0.002524673,0.0001866849,0.0002249765,0.0001778857,0.0007527092,0.00008934795,0.00004038315,0.0007684132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3719586,"threshold_uncertainty_score":0.9998352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025386509","doi":"10.3816/ccc.2006.n.024","title":"Capecitabine-Induced Cerebellar Toxicity","year":2006,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Toxicity; Neurotoxicity; Cerebellar ataxia; Prodrug; Ataxia; Fluorouracil; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Pharmacology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.05591288314114927,"gpt":0.4110532359609091,"spread":0.3551403528197598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002046839,0.0001932781,0.000514674,0.00004896281,0.00008131901,0.00001163984,0.00008931413,0.0002373058,0.003022046],"category_scores_gemma":[0.00006218035,0.0001602006,0.000288621,0.0002261921,0.0001398085,0.00004528222,0.00004667988,0.0003689158,0.0001660088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002457708,"about_ca_system_score_gemma":0.0003134851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007302325,"about_ca_topic_score_gemma":0.001514086,"domain_scores_codex":[0.9984259,0.00008049272,0.0005166386,0.0004209836,0.0002008619,0.0003551399],"domain_scores_gemma":[0.9991392,0.0002510667,0.0001147141,0.0001676696,0.0001217489,0.0002055425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002712025,0.001988928,0.861317,0.00006348528,0.000256179,0.0001763005,0.00003267766,0.000009434315,0.05003149,0.0002178778,0.07018815,0.01300638],"study_design_scores_gemma":[0.006612175,0.002471307,0.8721197,0.00004843705,0.0004579999,0.00003016914,0.00001373561,0.0001473523,0.06222788,0.0002693368,0.05530466,0.0002972275],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9696231,0.0009496654,0.000006032754,0.002589182,0.001559169,0.0004897557,0.00003869574,0.0001217468,0.02462264],"genre_scores_gemma":[0.9917276,0.0002393264,0.0001033876,0.001706155,0.00287306,0.0001219098,0.00004148826,0.0000289102,0.003158148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0221045,"threshold_uncertainty_score":0.9978893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164217435","doi":"10.1016/j.clcc.2021.05.004","title":"Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Canadian Cancer Society","keywords":"Medicine; Cardiorespiratory fitness; Colorectal cancer; Randomized controlled trial; Clinical trial; Physical therapy; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03809566803218854,"gpt":0.3944516257440872,"spread":0.3563559577118986,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008566399,0.0005666708,0.00493452,0.0001148472,0.0001821196,0.00003262292,0.00008521948,0.0003712401,0.001271871],"category_scores_gemma":[0.001748482,0.000396618,0.001265835,0.0003382264,0.0009551203,0.0001206369,0.0003316755,0.0003873369,0.000002720816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004553423,"about_ca_system_score_gemma":0.0008390755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002244254,"about_ca_topic_score_gemma":0.0002280614,"domain_scores_codex":[0.9951223,0.0007097409,0.002020381,0.001165348,0.0004675022,0.0005147827],"domain_scores_gemma":[0.9952262,0.002903834,0.0005243963,0.000399945,0.0003370766,0.0006085353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9361457,0.005188147,0.02572389,0.0001969329,0.001488974,0.0004998434,0.0003752441,0.000002898757,0.0003497787,0.000006114012,0.00001428414,0.03000819],"study_design_scores_gemma":[0.9016174,0.01203148,0.07868706,0.0008320596,0.003811315,0.00007185591,0.00003281881,0.0002311465,0.002194225,0.00004702893,0.0001149298,0.0003286604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9568383,0.03133113,0.000001599359,0.0008142592,0.0009811021,0.00919726,0.0001694205,0.0000753362,0.0005916494],"genre_scores_gemma":[0.9647183,0.02992624,0.00009456158,0.00008879494,0.0004271803,0.003254751,0.00002923315,0.00005724639,0.001403724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05296317,"threshold_uncertainty_score":0.9998485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W749808638","doi":"10.1016/j.clcc.2015.05.008","title":"Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Saskatchewan Cancer Agency","keywords":"Medicine; Hazard ratio; Asymptomatic; Primary tumor; Colorectal cancer; Surgery; Proportional hazards model; Stage (stratigraphy); Confidence interval; Chemotherapy; Cancer; Multivariate analysis; Internal medicine; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.04383241966405802,"gpt":0.3403864873302258,"spread":0.2965540676661678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006736401,0.0003717267,0.00122108,0.0002733926,0.00007829138,0.00002781127,0.0002931999,0.0002439137,0.0006737633],"category_scores_gemma":[0.0006051469,0.0002752876,0.0001561361,0.0007185875,0.0005949424,0.0003219838,0.00008733088,0.000604645,0.00001279696],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002754199,"about_ca_system_score_gemma":0.01298475,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03632608,"about_ca_topic_score_gemma":0.3477349,"domain_scores_codex":[0.9961426,0.0002697579,0.001338292,0.000737984,0.0008007704,0.0007106217],"domain_scores_gemma":[0.9972258,0.0005107543,0.0004674221,0.0003143538,0.0004650689,0.001016628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02467661,0.0005177032,0.9656107,0.0004922756,0.0001192139,0.0003693999,0.0008592308,0.000065494,0.0001055068,0.000004758486,0.0006964839,0.00648259],"study_design_scores_gemma":[0.01449174,0.008460443,0.9698355,0.000849418,0.000107359,0.0000334436,0.0003926187,0.001636737,0.0007034268,0.000003767913,0.003037447,0.0004481587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933708,0.000404515,0.000001128915,0.0002611253,0.0006150342,0.002021568,0.0002037803,0.00005982409,0.003062256],"genre_scores_gemma":[0.9973848,0.000123818,0.0002874723,0.0007237819,0.0001989007,0.0006621996,0.00006110421,0.00005685563,0.0005010794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3114088,"threshold_uncertainty_score":0.99997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2148727529","doi":"10.1016/j.clcc.2015.10.003","title":"Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bevacizumab; Irinotecan; Oxaliplatin; FOLFOX; Internal medicine; FOLFIRI; Colorectal cancer; Capecitabine; Oncology; Chemotherapy; Fluorouracil; Panitumumab; Regorafenib; Cetuximab; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1915098457326038,"gpt":0.4981416798138314,"spread":0.3066318340812276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001486683,0.0005629899,0.001839597,0.0001291736,0.0001211759,0.00004392947,0.0001846394,0.0003028379,0.0002144196],"category_scores_gemma":[0.001629819,0.0004213982,0.0007329117,0.0004215626,0.0003803755,0.0001904225,0.00009810003,0.0005059229,0.00003368426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001830479,"about_ca_system_score_gemma":0.001856233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002259833,"about_ca_topic_score_gemma":0.009093904,"domain_scores_codex":[0.9954592,0.0004038474,0.001675523,0.001134784,0.0005149491,0.0008116818],"domain_scores_gemma":[0.9952687,0.002557223,0.0005121692,0.0003389709,0.0006558184,0.0006671441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0298649,0.005071737,0.7491423,0.0001239031,0.002894011,0.0002163518,0.001164723,0.00003049511,0.00006613463,0.0000710457,0.006016789,0.2053376],"study_design_scores_gemma":[0.0497253,0.03541805,0.6901433,0.0004954275,0.004174286,0.0001077559,0.002094158,0.001559191,0.001221021,0.0003389402,0.213633,0.001089555],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741094,0.008785324,0.00005342009,0.008158625,0.002565563,0.003376897,0.0003311699,0.0001230455,0.002496555],"genre_scores_gemma":[0.9789571,0.008950312,0.001706891,0.003484551,0.001385381,0.004136934,0.0000672481,0.0001049581,0.001206697],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2076162,"threshold_uncertainty_score":0.9998238,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075229757","doi":"10.1016/j.clcc.2011.03.004","title":"Survival for Metastatic Colorectal Cancer in the Bevacizumab Era: A Population-based Analysis","year":2011,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Colorectal cancer; Internal medicine; Population; Cancer; Oncology; Chemotherapy; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1156545445334361,"gpt":0.4206176140579619,"spread":0.3049630695245258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009770313,0.0003696578,0.001288797,0.0002394623,0.0002223294,0.00002407917,0.0002455812,0.0001563353,0.0009357047],"category_scores_gemma":[0.0005034225,0.0002390349,0.000921448,0.00138027,0.0002241155,0.00008167523,0.00004928756,0.0004200226,0.000007207123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004830667,"about_ca_system_score_gemma":0.0005568866,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007030178,"about_ca_topic_score_gemma":0.07338678,"domain_scores_codex":[0.9969803,0.0002993649,0.0009796383,0.000713561,0.0004707183,0.0005563929],"domain_scores_gemma":[0.9974531,0.001513559,0.0002895869,0.0002803778,0.0002901286,0.0001732758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007958834,0.001204599,0.9725814,0.00007596768,0.002654069,0.00004330392,0.0008277506,0.0001435963,0.00001963475,0.0001165358,0.0004152307,0.01395907],"study_design_scores_gemma":[0.004924312,0.002096504,0.9846357,0.0000522369,0.004202046,0.000002359359,0.0003148284,0.002528929,0.0001511607,0.0002286977,0.0005803011,0.0002828974],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920751,0.001732839,0.0001179851,0.001422685,0.0008418575,0.002027139,0.000635437,0.00006226434,0.001084678],"genre_scores_gemma":[0.9942157,0.0002988201,0.0004870289,0.0009520102,0.000306515,0.003475795,0.0001087686,0.00003836433,0.0001169432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06635661,"threshold_uncertainty_score":0.9999776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997561975","doi":"10.3816/ccc.2006.n.030","title":"Randomized Clinical Trial of High-Dose Levamisole Combined with 5-Fluorouracil and Leucovorin as Surgical Adjuvant Therapy for High-Risk Colon Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Cancer Agency; Ontario Institute for Cancer Research; Centracare","funders":"National Cancer Institute","keywords":"Levamisole; Medicine; Regimen; Internal medicine; Gastroenterology; Colorectal cancer; Chemotherapy; Cancer; Surgery; Fluorouracil; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.04810227347382986,"gpt":0.3918049404833149,"spread":0.3437026670094851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002481179,0.0005331982,0.003658843,0.00008236512,0.0002276081,0.00003346939,0.0001566947,0.0004327115,0.0002512808],"category_scores_gemma":[0.0008635175,0.0003332793,0.0007992706,0.0002745949,0.001519664,0.00008831988,0.00009895297,0.0005801303,0.000004039106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002025368,"about_ca_system_score_gemma":0.0008816179,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01124663,"about_ca_topic_score_gemma":0.004542308,"domain_scores_codex":[0.9949723,0.000803893,0.002108882,0.0009949437,0.0005574533,0.0005624623],"domain_scores_gemma":[0.9916901,0.006125936,0.0009666882,0.0003333316,0.0005783733,0.0003055441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8730206,0.002298275,0.05850114,0.00006430523,0.001561604,0.00005476988,0.00004807307,0.00001444701,0.00001968664,0.0005056694,0.001457834,0.06245352],"study_design_scores_gemma":[0.8380023,0.04281579,0.1108771,0.0001662749,0.001595205,0.00001175731,0.00003909318,0.0001551874,0.000654822,0.000983234,0.004308341,0.0003909004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9817331,0.007469587,0.00002194237,0.001985361,0.001642504,0.006234792,0.0002824664,0.0000892826,0.0005409655],"genre_scores_gemma":[0.9697892,0.02328607,0.0003528795,0.000264911,0.001687715,0.003371254,0.0000740235,0.00007011635,0.001103841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06206262,"threshold_uncertainty_score":0.9999119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2790477022","doi":"10.1016/j.clcc.2018.01.010","title":"Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary; University of British Columbia; BC Cancer Agency","funders":"University of British Columbia; College of Family Physicians of Canada; American Society of Clinical Oncology","keywords":"FOLFOX; Medicine; Colorectal cancer; Internal medicine; Oncology; Adjuvant; Stage (stratigraphy); Overall survival; Oxaliplatin; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1390576990569576,"gpt":0.4851040353102704,"spread":0.3460463362533128,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841093,0.0002895301,0.001218768,0.00007979225,0.00007792555,0.000006947365,0.0001597079,0.0001562531,0.0008182688],"category_scores_gemma":[0.0001670216,0.0001605293,0.0005696805,0.000447589,0.0007651146,0.000045468,0.00005596874,0.0001704269,0.000005121535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008223978,"about_ca_system_score_gemma":0.0008411984,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0194444,"about_ca_topic_score_gemma":0.03533116,"domain_scores_codex":[0.9978037,0.0001796904,0.0008310365,0.0004102231,0.0003857121,0.0003895668],"domain_scores_gemma":[0.9980847,0.0008267997,0.0003398946,0.0003153024,0.0003105972,0.0001227649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05808078,0.002673209,0.8838157,0.00006966322,0.001862367,0.00006045494,0.003528832,0.00002326314,0.001009861,0.0000738063,0.001478401,0.04732367],"study_design_scores_gemma":[0.01493445,0.03784117,0.9411274,0.0001127564,0.0005152764,0.000001976631,0.0006114235,0.00009823889,0.002153025,0.00001778868,0.002419858,0.0001666084],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871498,0.005111684,8.394583e-7,0.0005522479,0.00128998,0.001017607,0.0002993686,0.00001690813,0.004561528],"genre_scores_gemma":[0.993535,0.004990641,0.0000174333,0.00006412982,0.0007055464,0.0003629625,0.00001375008,0.00002261263,0.0002879417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05731174,"threshold_uncertainty_score":0.9870852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000891188","doi":"10.3816/ccc.2008.n.051","title":"Trends in Chemotherapy Utilization for Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Stage (stratigraphy); Cancer; Adjuvant chemotherapy; Population; Chemotherapy; Oncology; Gastroenterology; Surgery; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1428829878580277,"gpt":0.4476129602540719,"spread":0.3047299723960442,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002548651,0.0003284312,0.0009347893,0.0002043605,0.0001976781,0.00001205886,0.0001165643,0.0002731142,0.001015594],"category_scores_gemma":[0.0001675504,0.0002686744,0.0004463539,0.0007286607,0.0003661851,0.00009659963,0.00004673122,0.000303797,0.000008588555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005948311,"about_ca_system_score_gemma":0.0004286188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005858721,"about_ca_topic_score_gemma":0.00452842,"domain_scores_codex":[0.997672,0.00006257187,0.0007605695,0.000687402,0.0002929387,0.0005245617],"domain_scores_gemma":[0.9988801,0.0003185711,0.0001837747,0.0001571307,0.0002480945,0.0002122878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009598227,0.0008027294,0.7814599,0.00004591196,0.0003143552,0.00004192366,0.0004809165,0.00001719841,0.000423345,0.00003695508,0.01250003,0.1942785],"study_design_scores_gemma":[0.008813974,0.002687197,0.9575824,0.0000972154,0.0001393457,0.00001989016,0.00005092873,0.0007588004,0.002620415,0.00005216107,0.02687482,0.0003028443],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871467,0.004426778,0.00002525891,0.00285506,0.001112938,0.001029404,0.0001233147,0.0001095935,0.003170974],"genre_scores_gemma":[0.9857523,0.007691905,0.0002144743,0.001333073,0.0008321902,0.001924868,0.00007084034,0.00005995726,0.002120427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1939756,"threshold_uncertainty_score":0.9999765,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793667162","doi":"10.1016/j.clcc.2018.02.010","title":"Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand–Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"M.S.I. Foundation; Japan Society for the Promotion of Science; National Cancer Institute; Krebsliga Schweiz; National Institutes of Health; Dhont Family Foundation","keywords":"Regorafenib; Medicine; Colorectal cancer; Cohort; CCL5; Internal medicine; Oncology; Single-nucleotide polymorphism; Hazard ratio; Biomarker; Genotype; Cancer; Immunology; Gene; Biology; Genetics; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.05299488738616756,"gpt":0.3645735590039721,"spread":0.3115786716178046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000718627,0.0003028863,0.0007370195,0.0001547389,0.0001174287,0.00004176886,0.000122029,0.0001969301,0.0001332864],"category_scores_gemma":[0.0003851411,0.0001909182,0.000153842,0.0005613846,0.0004609586,0.00007699564,0.00004088245,0.000335475,0.00000505667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002783914,"about_ca_system_score_gemma":0.0003094159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002109609,"about_ca_topic_score_gemma":0.007414603,"domain_scores_codex":[0.9975023,0.0002027187,0.0008799961,0.0006151508,0.0003353845,0.0004644492],"domain_scores_gemma":[0.9985575,0.0005921088,0.0002741292,0.0001724141,0.0002318806,0.0001719307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008370756,0.0006027787,0.949847,0.00004635869,0.000139759,0.00003334135,0.0004482876,0.000001932247,0.01236401,0.00000362345,0.0001938782,0.02794822],"study_design_scores_gemma":[0.009463049,0.004210973,0.9577909,0.0001996354,0.0002463995,0.000030519,0.00008053158,0.0008016973,0.02594246,0.000031497,0.0009217153,0.0002806336],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964986,0.0006170965,0.00001448572,0.0005855688,0.0003162032,0.001762593,0.00006828726,0.00002365414,0.0001134475],"genre_scores_gemma":[0.9976189,0.0001744642,0.0002540871,0.0005565827,0.0003592121,0.000827531,0.00005585658,0.00005103755,0.000102364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02766758,"threshold_uncertainty_score":0.7785418,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970115840","doi":"10.1016/j.clcc.2019.05.004","title":"KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Health Canada","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; KRAS; Internal medicine; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02431040169481003,"gpt":0.3589418487976663,"spread":0.3346314471028563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002498351,0.0003876491,0.001381417,0.0001287121,0.00005429846,0.00001363775,0.0001287391,0.0001587652,0.001601233],"category_scores_gemma":[0.0001298961,0.0002721295,0.0002576422,0.0005516479,0.0003574984,0.0001460856,0.00006629931,0.0004664477,0.00002461249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006199782,"about_ca_system_score_gemma":0.00111869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002103163,"about_ca_topic_score_gemma":0.003348588,"domain_scores_codex":[0.9972315,0.0001330601,0.0006926291,0.0007080654,0.0006331427,0.0006015649],"domain_scores_gemma":[0.9983052,0.0004374623,0.0003815859,0.0002477253,0.0003521165,0.0002758922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03674775,0.00193185,0.9346706,0.0001585777,0.0009238153,0.00001325318,0.0004188988,0.00001758382,0.0003252293,0.0000145365,0.0002030633,0.02457488],"study_design_scores_gemma":[0.01919513,0.01097915,0.9656075,0.0002989623,0.0003000746,0.00000131758,0.0000754022,0.00009000111,0.002281854,0.00004206553,0.0008477489,0.0002808099],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935662,0.000964772,0.000001518887,0.0004080939,0.000630621,0.002343757,0.0002539541,0.00005047238,0.001780628],"genre_scores_gemma":[0.9970474,0.00139139,0.000103072,0.0003735625,0.0001103882,0.00054384,0.00002395835,0.00005879332,0.000347612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03093692,"threshold_uncertainty_score":0.9999731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025899755","doi":"10.3816/ccc.2009.n.035","title":"Gene Expression Profiles as Predictors of Poor Outcomes in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis","year":2009,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Colorectal cancer; Meta-analysis; Oncology; Internal medicine; Odds ratio; Confidence interval; Stage (stratigraphy); Subgroup analysis; Adjuvant therapy; Cancer; Diagnostic odds ratio","retraction":null,"screen_n_in":null,"score":{"opus":0.130117514179371,"gpt":0.4571474967978107,"spread":0.3270299826184397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001856098,0.00147189,0.02990585,0.0006878719,0.0001207667,0.0000330115,0.0005718825,0.001082988,0.001994258],"category_scores_gemma":[0.002011514,0.0008846192,0.007675967,0.002466342,0.0004596788,0.0001460466,0.0004912067,0.001335193,0.00001634287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009799741,"about_ca_system_score_gemma":0.001582007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005510161,"about_ca_topic_score_gemma":0.0006488385,"domain_scores_codex":[0.9888818,0.00172457,0.005483601,0.001897618,0.00122835,0.0007840094],"domain_scores_gemma":[0.992739,0.002195922,0.003105249,0.0008598901,0.0003947464,0.0007052167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0007718753,0.001686908,0.00969022,0.7577093,0.2226864,0.0002883372,0.00007566088,0.000002789995,0.000004469066,0.000006828524,0.0003055365,0.006771734],"study_design_scores_gemma":[0.00149636,0.002823098,0.002338914,0.07329498,0.9121455,0.00003619966,0.00001154643,0.00000604816,0.00008915312,0.000007303762,0.006909645,0.000841253],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01196663,0.9721854,5.003972e-7,0.0003476208,0.0002916394,0.01299864,0.001845611,0.0001028452,0.0002611144],"genre_scores_gemma":[0.004105824,0.9818196,0.0001224944,0.0005914847,0.0001191858,0.01096034,0.0002376073,0.0001222142,0.001921219],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6894591,"threshold_uncertainty_score":0.9998031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103155016","doi":"10.1016/j.clcc.2013.11.002","title":"Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study","year":2013,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Bevacizumab; Medicine; Lactate dehydrogenase; Internal medicine; Colorectal cancer; Chemotherapy; Isozyme; Gastroenterology; Oncology; Cancer; Enzyme; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01024558012326759,"gpt":0.2934762160219493,"spread":0.2832306358986817,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000163214,0.0002655457,0.0007570525,0.00008738787,0.00005617742,0.00001186449,0.0001555873,0.0001489107,0.0000750723],"category_scores_gemma":[0.00006774003,0.0001443579,0.000112793,0.0008637744,0.0003403741,0.00002262848,0.00005123761,0.0002024275,2.862639e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008113254,"about_ca_system_score_gemma":0.0002372137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001132553,"about_ca_topic_score_gemma":0.01609096,"domain_scores_codex":[0.9981738,0.0001428896,0.0005645619,0.0005638979,0.0003023102,0.0002525102],"domain_scores_gemma":[0.9986152,0.00004624017,0.0005321311,0.0002636148,0.0004494026,0.0000933811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01518493,0.0005952364,0.9747366,0.00001576225,0.001090451,5.41462e-7,0.0001968286,0.0004508972,0.004583948,0.000001060962,0.00002752982,0.003116257],"study_design_scores_gemma":[0.00880271,0.009148756,0.9672419,0.00003892042,0.0007231451,5.386842e-7,0.000159147,0.0002682015,0.01334737,0.000001121496,0.00004094757,0.0002272379],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973668,0.0002913846,0.00001217221,0.00002987942,0.0001397791,0.001929485,0.0001844254,0.000009252378,0.0000368586],"genre_scores_gemma":[0.9989338,0.0002452768,0.00007200606,0.00004887335,0.00008024411,0.0004491862,0.00004442614,0.00003643413,0.00008978462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01495841,"threshold_uncertainty_score":0.8979136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063451985","doi":"10.3816/ccc.2008.n.025","title":"Adherence to Surveillance Guidelines After Curative Resection for Stage II/III Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Colorectal cancer; Carcinoembryonic antigen; Stage (stratigraphy); Internal medicine; Cancer; General surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1515735283653477,"gpt":0.4503831439193889,"spread":0.2988096155540412,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009061682,0.0004770992,0.001086988,0.0001875764,0.0005463676,0.00003381013,0.0002199662,0.0004409667,0.0009317549],"category_scores_gemma":[0.002005035,0.0004212508,0.0005550167,0.0009296772,0.0003731719,0.0002538826,0.0001882257,0.0006822814,0.0000317237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006448361,"about_ca_system_score_gemma":0.001082803,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002097673,"about_ca_topic_score_gemma":0.01798327,"domain_scores_codex":[0.9958921,0.0001671961,0.001345234,0.001221699,0.0006218425,0.0007519001],"domain_scores_gemma":[0.9962553,0.0006279021,0.0003756023,0.0003359242,0.001801346,0.0006039409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.401185,0.0007455274,0.4369538,0.0002583241,0.0007044611,0.0001375699,0.001759865,0.0006747543,0.009876381,0.00004029461,0.08793952,0.05972444],"study_design_scores_gemma":[0.01012619,0.06482759,0.7881127,0.0006590054,0.0002125532,0.0001172657,0.0002551132,0.004567513,0.03560662,0.00006030822,0.09412158,0.001333558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867882,0.001985107,0.001071795,0.00236214,0.003659881,0.002458826,0.0003553651,0.000310629,0.001008031],"genre_scores_gemma":[0.9820076,0.001462063,0.001261509,0.002124102,0.002658425,0.005096518,0.00003558253,0.00008179475,0.005272364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3910588,"threshold_uncertainty_score":0.9999815,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2956472396","doi":"10.1016/j.clcc.2019.07.005","title":"Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials","year":2019,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Body mass index; Chemotherapy; Oxaliplatin; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02343468710941693,"gpt":0.3804631684609261,"spread":0.3570284813515092,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004027988,0.0003964703,0.005941383,0.0003550947,0.00003478469,0.00001564334,0.0001332683,0.0002201077,0.0007997868],"category_scores_gemma":[0.002294513,0.0002394002,0.001367883,0.0009259739,0.0006545616,0.00005639581,0.00002536604,0.0003971187,0.000001402146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001874926,"about_ca_system_score_gemma":0.0003621907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001593857,"about_ca_topic_score_gemma":0.0006238309,"domain_scores_codex":[0.9950874,0.001532651,0.001746985,0.0006238813,0.0006914092,0.000317631],"domain_scores_gemma":[0.9871716,0.01048927,0.001480858,0.0002917912,0.0003123171,0.0002541769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3740146,0.0005365511,0.6104103,0.0001775699,0.006746723,0.000002126456,0.00004280917,0.00037397,0.0007980542,0.000001800543,0.00001943143,0.00687602],"study_design_scores_gemma":[0.2485154,0.008562264,0.7093771,0.0002819814,0.01196729,1.125087e-7,0.000005848256,0.007273506,0.01380968,0.000002145123,0.000008530977,0.0001962624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994311,0.0003743089,0.00006272292,0.00006467127,0.0002915304,0.004498051,0.0002926998,0.00003245035,0.00007250293],"genre_scores_gemma":[0.9988595,0.0003450362,0.00004109561,0.000209119,0.00006939864,0.0003458686,0.00006255478,0.00004323339,0.00002417495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1254993,"threshold_uncertainty_score":0.9762458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2957253824","doi":"10.1016/j.clcc.2019.07.007","title":"Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab","year":2019,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"European Society for Medical Oncology; Manitoba Beekeepers' Association; Gilead Sciences; Novartis; British Microcirculation Society; Amgen; Pfizer; F. Hoffmann-La Roche; Hellenic Cooperative Oncology Group; Roche; Meso Scale Diagnostics; Sanofi; Merck","keywords":"Bevacizumab; Medicine; Irinotecan; Colorectal cancer; Oncology; Internal medicine; Retrospective cohort study; Prospective cohort study; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.008801961380234487,"gpt":0.2903455097289728,"spread":0.2815435483487383,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004184296,0.0003907612,0.0007379377,0.0001179239,0.0000680489,0.00002766015,0.0001784057,0.0003341156,0.0000771944],"category_scores_gemma":[0.00005030956,0.0003389643,0.0001358476,0.0004707694,0.0002466128,0.00001802993,0.0001024049,0.0002482035,0.000003098123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003141896,"about_ca_system_score_gemma":0.0003239877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001752405,"about_ca_topic_score_gemma":0.008934888,"domain_scores_codex":[0.9972654,0.0001876115,0.0005361736,0.001267234,0.0002695417,0.0004740187],"domain_scores_gemma":[0.9991078,0.00006386009,0.0002239325,0.0002539438,0.0002013792,0.0001491209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006586363,0.0008534422,0.9871105,0.00001940395,0.0003377677,0.000008941285,0.00009223287,0.0000369365,0.003188326,0.000002085608,0.00003538927,0.001728633],"study_design_scores_gemma":[0.01070795,0.006319394,0.9762087,0.0000695118,0.00009365829,0.000002056065,0.00005715264,0.0001831742,0.005852102,0.000004762112,0.00004506431,0.0004564182],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950597,0.001736735,0.00000260861,0.00005221471,0.00016646,0.002690724,0.0001140062,0.00001872382,0.0001588115],"genre_scores_gemma":[0.9978459,0.001031739,0.00003116379,0.0001906415,0.0001320267,0.0006196637,0.00004018189,0.00006587275,0.000042752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01090172,"threshold_uncertainty_score":0.9999062,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151152779","doi":"10.3816/ccc.2008.n.031","title":"Lymph Node Evaluation in Early-Stage Colon Cancer","year":2008,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Colorectal cancer; Sentinel lymph node; Lymph node; Lymph; Stage (stratigraphy); Oncology; Biopsy; Cancer; Breast cancer; Melanoma; Internal medicine; Radiology; Pathology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.2162307945840904,"gpt":0.5040143930026015,"spread":0.2877835984185111,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001103883,0.001060422,0.005278429,0.0004185683,0.0001261024,0.00004076287,0.0004313028,0.001633834,0.00300134],"category_scores_gemma":[0.001053878,0.0008557446,0.001938896,0.001607575,0.0004954924,0.0001417326,0.0002667723,0.001751445,0.0003582019],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006053998,"about_ca_system_score_gemma":0.00667374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002183707,"about_ca_topic_score_gemma":0.001360937,"domain_scores_codex":[0.9920254,0.001120543,0.00264758,0.001812839,0.001411567,0.0009820232],"domain_scores_gemma":[0.9957067,0.001478432,0.001002437,0.0007004731,0.0004622717,0.000649701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001329256,0.0007473142,0.05758283,0.003436542,0.0007380505,0.0005121105,0.00005508283,0.00001284583,3.273645e-7,0.000005528304,0.00102178,0.9345583],"study_design_scores_gemma":[0.005922463,0.0008332835,0.08284012,0.01608536,0.002692001,0.00008103582,0.000005603795,0.0001884027,0.0000037456,0.00001223082,0.8904501,0.0008856141],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06671238,0.9204316,5.816169e-7,0.000131543,0.002696201,0.00488896,0.0003577661,0.0001409182,0.00464006],"genre_scores_gemma":[0.004729643,0.9826866,0.00005370218,0.0003594052,0.001369836,0.008723274,0.0002699492,0.0002084205,0.001599128],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9336727,"threshold_uncertainty_score":0.9996623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2258875446","doi":"10.1016/j.clcc.2016.02.011","title":"Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Colorectal Cancer","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto","funders":"","keywords":"Hypomagnesemia; Medicine; Jadad scale; Internal medicine; Randomized controlled trial; Discontinuation; Cochrane Library; Magnesium","retraction":null,"screen_n_in":null,"score":{"opus":0.09573118593050471,"gpt":0.4342093212643262,"spread":0.3384781353338215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001677222,0.0009150552,0.007133859,0.0001265453,0.0001195249,0.00002981383,0.0008925377,0.0008850502,0.001609482],"category_scores_gemma":[0.003084127,0.0005938319,0.002243755,0.0006620561,0.0002158942,0.0001405152,0.0002854242,0.0009568164,0.0006598987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005928093,"about_ca_system_score_gemma":0.0005510365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003893431,"about_ca_topic_score_gemma":0.000005864117,"domain_scores_codex":[0.9894806,0.002282368,0.005404649,0.001176775,0.0007923035,0.0008632898],"domain_scores_gemma":[0.9919133,0.00284223,0.003034122,0.0009310945,0.0003967193,0.0008825057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001582754,0.0001432397,0.00001860106,0.7224387,0.0001262257,0.0000241222,0.000004466311,1.383704e-9,3.404052e-7,0.00001971982,0.003061047,0.2740053],"study_design_scores_gemma":[0.0007246675,0.0007775237,0.00005021041,0.911764,0.00697487,0.000010449,0.000005045156,5.293065e-7,0.000007120292,0.00002478274,0.07888726,0.000773502],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001927867,0.9822044,0.000001078462,0.0005071739,0.006547333,0.00910056,0.0006110666,0.000134741,0.0007008206],"genre_scores_gemma":[0.0005892012,0.99289,0.00005936579,0.0008568703,0.001263632,0.003898463,0.00005975347,0.0001444171,0.0002382708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2732318,"threshold_uncertainty_score":0.9996513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770135955","doi":"10.1016/j.clcc.2017.11.001","title":"Primary Tumor Location and Survival in the General Population With Metastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Saskatchewan Cancer Agency","keywords":"Colorectal cancer; Medicine; Oncology; Primary tumor; Internal medicine; Population; Cancer; Metastasis; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.06334966421222735,"gpt":0.403618124264216,"spread":0.3402684600519886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006106567,0.0002576989,0.0006772042,0.00005358226,0.0004297894,0.00009992583,0.0001757014,0.00007355257,0.00006203764],"category_scores_gemma":[0.0002667795,0.000151261,0.00009729715,0.0001651492,0.0004644377,0.0001851674,0.00009483189,0.0003568958,0.000003232549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003201556,"about_ca_system_score_gemma":0.0003310547,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005792121,"about_ca_topic_score_gemma":0.0283558,"domain_scores_codex":[0.9981208,0.0001690286,0.0004803282,0.0005041226,0.0003976728,0.0003280826],"domain_scores_gemma":[0.9988119,0.0003121268,0.0003116457,0.0002715373,0.0001737913,0.0001190087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003765397,0.0002591763,0.9714634,0.00009492967,0.0002201407,0.00008390174,0.0002874025,0.0000194932,0.00008572388,0.0001265544,0.0002411408,0.02335274],"study_design_scores_gemma":[0.003698488,0.001506393,0.9929253,0.0001570495,0.0003575417,0.00003039968,0.0001421021,0.0003776646,0.0000713523,0.00009272524,0.0004458552,0.0001950752],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914296,0.001971117,0.000006619061,0.00302424,0.0005527257,0.001058903,0.00003737271,0.00002884183,0.001890612],"genre_scores_gemma":[0.9964515,0.001070845,0.0001598389,0.0008433981,0.0004749402,0.0007706804,0.00003150719,0.00002716533,0.0001701285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02315767,"threshold_uncertainty_score":0.9893742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1172128302","doi":"10.1016/j.clcc.2015.07.002","title":"Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Canadian Cancer Society Research Institute","keywords":"Medicine; Colorectal cancer; Hazard ratio; Internal medicine; Proportional hazards model; Confounding; Confidence interval; Weight loss; Obesity; Cancer; Stage (stratigraphy); Body mass index; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.1168556156195256,"gpt":0.4373147368660846,"spread":0.3204591212465591,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083608,0.0002623429,0.001003917,0.0001032064,0.00004691775,0.00001022334,0.0001780689,0.0002390741,0.0007431986],"category_scores_gemma":[0.0006911124,0.0001529315,0.0005378638,0.0004321515,0.0004006039,0.00005178634,0.00009834217,0.0004676002,0.000007186466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003813909,"about_ca_system_score_gemma":0.0005692088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005353983,"about_ca_topic_score_gemma":0.009632281,"domain_scores_codex":[0.9977958,0.0002260126,0.0006541683,0.0003945947,0.0006047304,0.0003247523],"domain_scores_gemma":[0.9974818,0.0009943355,0.0004182204,0.0003549589,0.0004656522,0.0002850102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04394708,0.0003587686,0.9328651,0.00005099304,0.0004281469,0.000009570443,0.0003440556,0.0000929692,0.00009344828,0.000009266568,0.001656687,0.02014385],"study_design_scores_gemma":[0.003558032,0.0149312,0.9743851,0.0001783117,0.000276055,0.000002191897,0.0001054079,0.0002293179,0.004124764,0.00001861645,0.002010528,0.0001804876],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924443,0.002183136,0.000008484782,0.00159922,0.001768637,0.0006468673,0.0001808625,0.00004864552,0.001119897],"genre_scores_gemma":[0.9966651,0.001012749,0.00001819754,0.0003870316,0.0005970125,0.000763915,0.000006316775,0.00003450908,0.0005151356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04151993,"threshold_uncertainty_score":0.8137503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W846103264","doi":"10.1016/j.clcc.2015.05.010","title":"Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"FOLFOX; Medicine; Internal medicine; Oxaliplatin; Colorectal cancer; Hazard ratio; Discontinuation; Proportional hazards model; Oncology; Odds ratio; Cancer; Surgery; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.03846909928019735,"gpt":0.397626169375371,"spread":0.3591570700951737,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049409,0.000338539,0.001503908,0.00008997892,0.00003280998,0.000006552541,0.0001361933,0.0002275593,0.0003655076],"category_scores_gemma":[0.0004566786,0.0002098764,0.0003065272,0.0003661033,0.000322464,0.00008505998,0.00004930158,0.0003002119,0.000009959704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004939282,"about_ca_system_score_gemma":0.0004646371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004616278,"about_ca_topic_score_gemma":0.0003649357,"domain_scores_codex":[0.997204,0.0002408062,0.0009317894,0.0004955294,0.0008181167,0.0003097451],"domain_scores_gemma":[0.9973388,0.0008655534,0.0006291741,0.0003117121,0.0005200657,0.0003347473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06913915,0.001070999,0.9047993,0.0001274933,0.0005198138,0.00001131314,0.0001155533,0.000039185,0.0001060245,0.000009653068,0.0003621829,0.02369929],"study_design_scores_gemma":[0.02747408,0.03652098,0.9133186,0.0002403803,0.0003568672,4.780486e-7,0.00001328041,0.00008284501,0.02071549,0.000007228527,0.001068296,0.0002014169],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953201,0.0003174328,0.000004446208,0.0003261414,0.0007037374,0.001859563,0.0001883337,0.00004903384,0.001231197],"genre_scores_gemma":[0.998372,0.0001662028,0.00004869711,0.0003483485,0.0001153171,0.0003989221,0.00004956909,0.00004905245,0.0004519567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04166507,"threshold_uncertainty_score":0.8558513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978608893","doi":"10.1016/j.clcc.2012.11.002","title":"Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405","year":2013,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Sanofi; Pfizer; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Colorectal cancer; Internal medicine; Cancer; Body mass index; Stage (stratigraphy); Cohort; Chemotherapy; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.04497719912630243,"gpt":0.3686827843079433,"spread":0.3237055851816408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003550312,0.0004041004,0.001349899,0.0001308554,0.0001944048,0.00006338546,0.0001042259,0.0003097907,0.0004126348],"category_scores_gemma":[0.000573763,0.0003463818,0.0001566697,0.0003002406,0.0009777042,0.0002977191,0.0002335463,0.0007307127,0.000005183907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001474749,"about_ca_system_score_gemma":0.0001792529,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01823425,"about_ca_topic_score_gemma":0.007172774,"domain_scores_codex":[0.9969471,0.0001964654,0.001103956,0.0008515816,0.0004426749,0.0004582338],"domain_scores_gemma":[0.9973994,0.001070923,0.0004133426,0.0001810611,0.0003383535,0.0005968426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004033506,0.0003005661,0.9658121,0.0001687602,0.000295959,0.000005946464,0.0007726803,0.00000598413,0.00172504,0.000003792273,0.001083557,0.02579205],"study_design_scores_gemma":[0.004576457,0.006187667,0.9783582,0.0003148958,0.0004957813,0.000003979093,0.0003379277,0.005346379,0.003698377,0.00004767315,0.0002645967,0.0003680394],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925995,0.0046802,0.00001913215,0.0003325272,0.0006277354,0.00124529,0.0002297644,0.00008516617,0.0001806335],"genre_scores_gemma":[0.9974309,0.001052284,0.0003358097,0.0003109182,0.0002145426,0.0003877613,0.00005263172,0.00004979103,0.0001654042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02542401,"threshold_uncertainty_score":0.9998988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766962807","doi":"10.1016/j.clcc.2017.10.010","title":"Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Colorectal cancer; Profiling (computer programming); Cancer; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02862975134718337,"gpt":0.3768540610803594,"spread":0.348224309733176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001819474,0.0005281832,0.001344561,0.00007156839,0.0004914348,0.00005950465,0.0004945463,0.0002411087,0.0004485368],"category_scores_gemma":[0.0003890853,0.0003855736,0.0003350822,0.0002259421,0.001156384,0.0002827529,0.0003501876,0.0004832383,0.000004254045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005193055,"about_ca_system_score_gemma":0.0008081745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00127432,"about_ca_topic_score_gemma":0.003177345,"domain_scores_codex":[0.9964588,0.00008660081,0.0009021611,0.001040025,0.0007861943,0.0007261981],"domain_scores_gemma":[0.9969492,0.0001667485,0.0009561391,0.0005855598,0.0009484275,0.0003939549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0100158,0.0006788498,0.9451148,0.0001890092,0.0006397506,0.00005633694,0.0004365343,0.00006875253,0.00104386,0.00004175584,0.0001176145,0.04159691],"study_design_scores_gemma":[0.007064881,0.002149228,0.9501658,0.0006812401,0.0004488976,0.000001562236,0.0002040999,0.0001271659,0.03733841,0.00001611464,0.001332927,0.0004696622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905301,0.003100077,0.000006907774,0.0009769024,0.001318423,0.00195531,0.0004016557,0.00008197861,0.001628652],"genre_scores_gemma":[0.9948541,0.002638706,0.0004233966,0.0002688885,0.0002613257,0.001289588,0.00003193068,0.00007638852,0.0001556917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04112725,"threshold_uncertainty_score":0.9998596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}